A detailed history of David Einhorn (Greenlight Capital Inc) transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Greenlight Capital Inc holds 34,995 shares of NUVB stock, worth $102,535. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,995
Previous 34,995 -0.0%
Holding current value
$102,535
Previous $62,000 16.13%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$9.22 - $14.48 $1.06 Million - $1.67 Million
-115,005 Reduced 76.67%
34,995 $326,000
Q1 2021

May 17, 2021

BUY
$9.0 - $14.57 $1.35 Million - $2.19 Million
150,000 New
150,000 $1.57 Million

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $637M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track David Einhorn's Portfolio

Track David Einhorn Portfolio

Follow David Einhorn (Greenlight Capital Inc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenlight Capital Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greenlight Capital Inc and David Einhorn with notifications on news.